Rising Labor Cost Top Risk For Multinationals In China – AmCham Survey
This article was originally published in PharmAsia News
Executive Summary
A slowing economy and regulatory uncertainty loom large for multinationals operating in China. However, companies say rising labor costs impact them more, and acute shortages of qualified employees further complicate the landscape.
You may also be interested in...
Chinese Government Takes First Steps To De-link Indigenous Innovation And Procurement, But Industry Groups Wary
SHANGHAI - Months after pledging a policy change, China is finally taking steps to break ties between indigenous innovation and government procurement policies. The changes in policy, according to a report released by the U.S.-China Business Council, address growing concern among multinationals that procurement policies - an estimated $1 trillion market - are increasingly designed to shut them out
Are China's Rising Labor Costs Good For Big Pharma?
HONG KONG - Rising labor costs are putting stress on manufacturing operations in China, but may prove to be a boon in the long term for companies focused on the world's fastest-growing domestic market
U.S. Companies Doing Well In China; Express Concerns About Business Climate - Survey
HONG KONG - Most U.S. companies in China are doing well and expect to expand operations this year, but bureaucracy and unclear laws and regulations are impeding their plans, the 2011 Business Climate Survey by the American Chamber of Commerce in the People's Republic of China shows